JP2014110814A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014110814A5 JP2014110814A5 JP2014057616A JP2014057616A JP2014110814A5 JP 2014110814 A5 JP2014110814 A5 JP 2014110814A5 JP 2014057616 A JP2014057616 A JP 2014057616A JP 2014057616 A JP2014057616 A JP 2014057616A JP 2014110814 A5 JP2014110814 A5 JP 2014110814A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- mouse
- gene
- gene segment
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 claims 89
- 210000004027 cell Anatomy 0.000 claims 23
- 238000003780 insertion Methods 0.000 claims 14
- 230000037431 insertion Effects 0.000 claims 14
- 101000998953 Homo sapiens Immunoglobulin heavy variable 1-2 Proteins 0.000 claims 7
- 102100036887 Immunoglobulin heavy variable 1-2 Human genes 0.000 claims 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 7
- 239000000427 antigen Substances 0.000 claims 7
- 102000036639 antigens Human genes 0.000 claims 7
- 108091007433 antigens Proteins 0.000 claims 7
- 150000007523 nucleic acids Chemical group 0.000 claims 7
- 210000003719 b-lymphocyte Anatomy 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- 210000004408 hybridoma Anatomy 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 238000011144 upstream manufacturing Methods 0.000 claims 4
- 210000001161 mammalian embryo Anatomy 0.000 claims 3
- 101710098119 Chaperonin GroEL 2 Proteins 0.000 claims 2
- 108020004414 DNA Proteins 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 210000001671 embryonic stem cell Anatomy 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims 1
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims 1
- 241000283984 Rodentia Species 0.000 claims 1
- 210000001185 bone marrow Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 210000001165 lymph node Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000000952 spleen Anatomy 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161446895P | 2011-02-25 | 2011-02-25 | |
| US61/446,895 | 2011-02-25 | ||
| US201161497650P | 2011-06-16 | 2011-06-16 | |
| US61/497,650 | 2011-06-16 | ||
| US201261595200P | 2012-02-06 | 2012-02-06 | |
| US61/595,200 | 2012-02-06 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013550677A Division JP2014507137A (ja) | 2011-02-25 | 2012-02-24 | Ａｄａｍ６マウス |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015036588A Division JP2015107131A (ja) | 2011-02-25 | 2015-02-26 | Ａｄａｍ６マウス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014110814A JP2014110814A (ja) | 2014-06-19 |
| JP2014110814A5 true JP2014110814A5 (enExample) | 2015-04-09 |
| JP5866127B2 JP5866127B2 (ja) | 2016-02-17 |
Family
ID=45998616
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013550677A Pending JP2014507137A (ja) | 2011-02-25 | 2012-02-24 | Ａｄａｍ６マウス |
| JP2014057616A Active JP5866127B2 (ja) | 2011-02-25 | 2014-03-20 | Ａｄａｍ６マウス |
| JP2015036588A Withdrawn JP2015107131A (ja) | 2011-02-25 | 2015-02-26 | Ａｄａｍ６マウス |
| JP2016088848A Withdrawn JP2016135143A (ja) | 2011-02-25 | 2016-04-27 | Ａｄａｍ６マウス |
| JP2018107070A Withdrawn JP2018143250A (ja) | 2011-02-25 | 2018-06-04 | Ａｄａｍ６マウス |
| JP2019127562A Withdrawn JP2019187446A (ja) | 2011-02-25 | 2019-07-09 | Ａｄａｍ６マウス |
| JP2022029501A Pending JP2022071051A (ja) | 2011-02-25 | 2022-02-28 | Ａｄａｍ６マウス |
| JP2024212173A Pending JP2025032218A (ja) | 2011-02-25 | 2024-12-05 | Ａｄａｍ６マウス |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013550677A Pending JP2014507137A (ja) | 2011-02-25 | 2012-02-24 | Ａｄａｍ６マウス |
Family Applications After (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015036588A Withdrawn JP2015107131A (ja) | 2011-02-25 | 2015-02-26 | Ａｄａｍ６マウス |
| JP2016088848A Withdrawn JP2016135143A (ja) | 2011-02-25 | 2016-04-27 | Ａｄａｍ６マウス |
| JP2018107070A Withdrawn JP2018143250A (ja) | 2011-02-25 | 2018-06-04 | Ａｄａｍ６マウス |
| JP2019127562A Withdrawn JP2019187446A (ja) | 2011-02-25 | 2019-07-09 | Ａｄａｍ６マウス |
| JP2022029501A Pending JP2022071051A (ja) | 2011-02-25 | 2022-02-28 | Ａｄａｍ６マウス |
| JP2024212173A Pending JP2025032218A (ja) | 2011-02-25 | 2024-12-05 | Ａｄａｍ６マウス |
Country Status (31)
| Country | Link |
|---|---|
| US (12) | US8642835B2 (enExample) |
| EP (7) | EP2813573B1 (enExample) |
| JP (8) | JP2014507137A (enExample) |
| KR (1) | KR101387377B1 (enExample) |
| CN (2) | CN103429746B (enExample) |
| AU (6) | AU2012243291B2 (enExample) |
| BR (1) | BR112013021771B1 (enExample) |
| CA (1) | CA2820824A1 (enExample) |
| CY (5) | CY1116301T1 (enExample) |
| DE (5) | DE14154967T1 (enExample) |
| DK (6) | DK2550363T3 (enExample) |
| ES (6) | ES2532487T3 (enExample) |
| FI (3) | FI2578688T4 (enExample) |
| HR (5) | HRP20230526T1 (enExample) |
| HU (5) | HUE062552T2 (enExample) |
| IL (4) | IL226727A (enExample) |
| IN (1) | IN2013CN07629A (enExample) |
| LT (4) | LT2738259T (enExample) |
| ME (3) | ME03732B (enExample) |
| MX (3) | MX375115B (enExample) |
| MY (1) | MY172713A (enExample) |
| NZ (3) | NZ813867A (enExample) |
| PL (5) | PL4067496T3 (enExample) |
| PT (5) | PT2738259T (enExample) |
| RS (5) | RS53880B1 (enExample) |
| RU (2) | RU2722373C2 (enExample) |
| SG (4) | SG10201405135RA (enExample) |
| SI (5) | SI2578688T2 (enExample) |
| SM (5) | SMT201900581T1 (enExample) |
| WO (1) | WO2012141798A1 (enExample) |
| ZA (1) | ZA201305998B (enExample) |
Families Citing this family (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050144655A1 (en) | 2000-10-31 | 2005-06-30 | Economides Aris N. | Methods of modifying eukaryotic cells |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| EP2314629B2 (en) | 2002-07-18 | 2022-11-16 | Merus N.V. | Recombinant production of mixtures of antibodies |
| USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
| US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
| WO2004106375A1 (en) | 2003-05-30 | 2004-12-09 | Merus Biopharmaceuticals B.V. I.O. | Fab library for the preparation of anti vegf and anti rabies virus fabs |
| EP1978032A3 (en) | 2004-07-22 | 2009-02-18 | Erasmus University Medical Center Rotterdam | Binding molecules |
| GB0905023D0 (en) | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
| CN102638971B (zh) * | 2009-07-08 | 2015-10-07 | 科马布有限公司 | 动物模型及治疗分子 |
| US9445581B2 (en) | 2012-03-28 | 2016-09-20 | Kymab Limited | Animal models and therapeutic molecules |
| US20130045492A1 (en) | 2010-02-08 | 2013-02-21 | Regeneron Pharmaceuticals, Inc. | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
| US9796788B2 (en) | 2010-02-08 | 2017-10-24 | Regeneron Pharmaceuticals, Inc. | Mice expressing a limited immunoglobulin light chain repertoire |
| HRP20151188T4 (hr) | 2010-02-08 | 2021-10-01 | Regeneron Pharmaceuticals, Inc. | Miš sa zajedničkim lakim lancem |
| KR102306967B1 (ko) | 2010-08-02 | 2021-10-01 | 리제너론 파아마슈티컬스, 인크. | Ｖｌ 도메인을 포함하는 결합 단백질을 생성하는 마우스 |
| LT2738259T (lt) | 2011-02-25 | 2020-03-10 | Regeneron Pharmaceuticals, Inc. | Adam6 pelės |
| AU2012279018B2 (en) | 2011-07-05 | 2017-06-08 | Children's Medical Center Corporation | N-terminal deleted GP120 immunogens |
| PT3865581T (pt) * | 2011-08-05 | 2024-10-04 | Regeneron Pharma | Murganhos da cadeia leve universal humanizada |
| AU2012311286B2 (en) | 2011-09-19 | 2018-07-26 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
| EP3741862A1 (en) | 2011-09-19 | 2020-11-25 | Kymab Limited | Animals, repertoires & methods for the production of human antibodies |
| WO2013045916A1 (en) | 2011-09-26 | 2013-04-04 | Kymab Limited | Chimaeric surrogate light chains (slc) comprising human vpreb |
| CA2850745C (en) | 2011-10-03 | 2022-12-13 | Duke University | Vaccine |
| KR20140082824A (ko) * | 2011-10-17 | 2014-07-02 | 리제너론 파아마슈티컬스, 인크. | 제한된 면역글로불린 중쇄 마우스 |
| US20180295821A1 (en) * | 2011-12-02 | 2018-10-18 | Kymab Limited | Transgenic Animals |
| GB201122047D0 (en) * | 2011-12-21 | 2012-02-01 | Kymab Ltd | Transgenic animals |
| US9253965B2 (en) | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
| PT3527070T (pt) | 2011-12-20 | 2025-12-19 | Regeneron Pharma | Murganhos de cadeia leve humanizada |
| NZ810648A (en) * | 2012-02-01 | 2025-11-28 | Regeneron Pharma | Humanized rodents that express heavy chains containing vl domains |
| HK1200271A1 (en) | 2012-03-16 | 2015-08-07 | 瑞泽恩制药公司 | Mice that produce antigen-binding proteins with ph-dependent binding characteristics |
| US20140013456A1 (en) | 2012-03-16 | 2014-01-09 | Regeneron Pharmaceuticals, Inc. | Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same |
| DK2825036T3 (en) | 2012-03-16 | 2018-07-16 | Regeneron Pharma | Histidine engineered light chain antibodies and genetically modified rodents to generate them |
| KR102213535B1 (ko) | 2012-03-16 | 2021-02-08 | 리제너론 파마슈티칼스 인코포레이티드 | pH-민감성 면역글로불린 서열을 발현하는 비-사람 동물 |
| GB2502127A (en) * | 2012-05-17 | 2013-11-20 | Kymab Ltd | Multivalent antibodies and in vivo methods for their production |
| US10251377B2 (en) | 2012-03-28 | 2019-04-09 | Kymab Limited | Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies |
| DK2838918T3 (da) | 2012-04-20 | 2019-08-12 | Merus Nv | Fremgangsmåder og midler til fremstilling af heterodimere ig-lignende molekyler |
| EP3912464A1 (en) * | 2012-06-12 | 2021-11-24 | Regeneron Pharmaceuticals, Inc. | Humanized non-human animals with restricted immunoglobulin heavy chain loci |
| AU2014214863B2 (en) | 2013-02-06 | 2019-03-21 | Duke University | B cell lineage based immunogen design with humanized animals |
| MY185881A (en) | 2013-02-20 | 2021-06-14 | Regeneron Pharma | Non-human animals with modified immunoglobulin heavy chain sequences |
| PL2967012T3 (pl) * | 2013-03-14 | 2021-04-19 | Erasmus University Medical Center Rotterdam | Transgeniczne ssaki inne niż człowiek do wytwarzania przeciwciał |
| WO2014141192A1 (en) * | 2013-03-15 | 2014-09-18 | Erasmus University Medical Center | Generation of heavy chain-only antibodies |
| US9788534B2 (en) | 2013-03-18 | 2017-10-17 | Kymab Limited | Animal models and therapeutic molecules |
| US9783618B2 (en) | 2013-05-01 | 2017-10-10 | Kymab Limited | Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics |
| US11707056B2 (en) | 2013-05-02 | 2023-07-25 | Kymab Limited | Animals, repertoires and methods |
| US9783593B2 (en) | 2013-05-02 | 2017-10-10 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
| CA2925723A1 (en) | 2013-10-01 | 2015-04-09 | Kymab Limited | Animal models and therapeutic molecules |
| JP6267986B2 (ja) * | 2014-02-13 | 2018-01-24 | 株式会社特殊免疫研究所 | ヒトの特定分子と結合する分子標的物質のｉｎｖｉｖｏ評価法 |
| CN106255410B (zh) * | 2014-03-21 | 2020-01-10 | 瑞泽恩制药公司 | 产生单结构域结合蛋白的非人动物 |
| CN106164092A (zh) | 2014-03-21 | 2016-11-23 | 瑞泽恩制药公司 | 表现不同结合特征的vl抗原结合蛋白 |
| KR20170083534A (ko) | 2014-09-19 | 2017-07-18 | 리제너론 파마슈티칼스 인코포레이티드 | 키메라 항원 수용체 |
| US11111314B2 (en) | 2015-03-19 | 2021-09-07 | Regeneron Pharmaceuticals, Inc. | Non-human animals that select for light chain variable regions that bind antigen |
| TW202417497A (zh) | 2015-10-12 | 2024-05-01 | 美商再生元醫藥公司 | 活化瘦素受體的抗原結合蛋白 |
| IL302725A (en) | 2016-01-13 | 2023-07-01 | Regeneron Pharma | Rodents having an engineered heavy chain diversity region |
| SG11201806427WA (en) | 2016-02-16 | 2018-08-30 | Regeneron Pharma | Non-human animals having a mutant kynureninase gene |
| US20170332610A1 (en) * | 2016-05-20 | 2017-11-23 | Regeneron Pharmaceuticals, Inc. | Methods for breaking immunological tolerance using multiple guide rnas |
| KR102483193B1 (ko) | 2016-06-03 | 2023-01-04 | 리제너론 파마슈티칼스 인코포레이티드 | 외인성 말단 데옥시뉴클레오타이드 전달효소를 발현하는 비인간 동물 |
| WO2017214089A1 (en) * | 2016-06-06 | 2017-12-14 | Regeneron Pharmaceuticals, Inc. | Non-human animals expressing antibodies with human lambda light chains |
| PT4082334T (pt) | 2016-11-04 | 2025-05-21 | Regeneron Pharma | Animais não humanos possuindo um lócus da cadeia leve lambda de immunoglobulina geneticamente modificada |
| US11122042B1 (en) | 2017-05-12 | 2021-09-14 | F5 Networks, Inc. | Methods for dynamically managing user access control and devices thereof |
| ES3065816T3 (en) | 2017-06-07 | 2026-05-08 | Regeneron Pharma | Compositions and methods for internalizing enzymes |
| TW202438676A (zh) | 2017-12-05 | 2024-10-01 | 美商再生元醫藥公司 | 具有經改造免疫球蛋白λ輕鏈的非人類動物及其用途 |
| CN112040985A (zh) | 2018-02-07 | 2020-12-04 | 瑞泽恩制药公司 | 用于递送治疗性蛋白质的方法和组合物 |
| US20210000088A1 (en) | 2018-03-21 | 2021-01-07 | Crystal Bioscience Inc. | Transgenic chicken that produces human antibodies |
| SG11202008799PA (en) | 2018-03-24 | 2020-10-29 | Regeneron Pharma | Genetically modified non-human animals for generating therapeutic antibodies against peptide-mhc complexes, methods of making and uses thereof |
| WO2019190990A1 (en) | 2018-03-26 | 2019-10-03 | Regeneron Pharmaceuticals, Inc. | Humanized rodents for testing therapeutic agents |
| LT3773713T (lt) | 2018-04-06 | 2025-08-25 | Regeneron Pharmaceuticals, Inc. | Leptino receptoriaus agonistinis antikūnas, skirtas kaulų masės didinimui subjektui, kuriam pasireiškia medžiagų apykaitos sutrikimas arba hipoleptinemija |
| BR112020023145A2 (pt) | 2018-05-17 | 2021-02-02 | Regeneron Pharmaceuticals, Inc. | anticorpo anti-cd63 ou fragmento de ligação ao antígeno do mesmo, molécula de ligação ao antígeno biespecífica, proteína terapêutica de múltiplos domínios, polinucleotídeo composição farmacêutica, e, composto |
| WO2019240999A1 (en) * | 2018-06-13 | 2019-12-19 | Crystal Bioscience Inc. | Camelization of a human variable domain by gene conversion |
| IL318469A (en) | 2018-06-14 | 2025-03-01 | Regeneron Pharma | Non-human animals capable of reorganizing transgenic DH-DH, and their uses |
| CA3125380A1 (en) | 2019-02-18 | 2020-08-27 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Genetically modified non-human animals with humanized immunoglobulin locus |
| SG11202107589PA (en) | 2019-02-22 | 2021-08-30 | Regeneron Pharma | Rodents having genetically modified sodium channels and methods of use thereof |
| SG11202111258TA (en) | 2019-06-05 | 2021-11-29 | Regeneron Pharma | Non-human animals having a limited lambda light chain repertoire expressed from the kappa locus and uses thereof |
| DK3785536T4 (da) * | 2019-08-28 | 2025-10-27 | Trianni Inc | Adam6-knockin-mus |
| IL293330A (en) | 2019-12-02 | 2022-07-01 | Regeneron Pharma | mhc ii peptide protein structures and uses thereof |
| KR20230018439A (ko) | 2020-06-02 | 2023-02-07 | 바이오사이토젠 파마슈티컬스 (베이징) 컴퍼니 리미티드 | 공동 경쇄 면역글로불린 좌위를 갖는 유전자 변형 비인간 동물 |
| KR20230066386A (ko) | 2020-09-11 | 2023-05-15 | 리제너론 파마슈티칼스 인코포레이티드 | 항원 특이적 항체의 확인 및 제조 |
| AU2021400584A1 (en) | 2020-12-16 | 2023-06-29 | Regeneron Pharmaceuticals, Inc. | Mice expressing humanized fc alpha receptors |
| KR20230124594A (ko) | 2020-12-23 | 2023-08-25 | 리제너론 파마슈티칼스 인코포레이티드 | 막관통 단백질 및 이를 생산하는 세포에 결합하는 항체를 수득하는 방법 |
| US20240317849A1 (en) | 2020-12-23 | 2024-09-26 | Regeneron Pharmaceuticals, Inc. | Nucleic acids encoding anchor modified antibodies and uses thereof |
| WO2022225985A1 (en) | 2021-04-20 | 2022-10-27 | Regeneron Pharmaceuticals, Inc. | Human antibodies to artemin and methods of use thereof |
| WO2024015816A1 (en) | 2022-07-12 | 2024-01-18 | Regeneron Pharmaceuticals, Inc. | Antibodies to ciliary neurotrophic factor receptor (cntfr) and methods of use thereof |
| KR20250150011A (ko) | 2023-02-13 | 2025-10-17 | 리제너론 파마슈티칼스 인코포레이티드 | 항-인간 cacng1 항체를 이용한 근육 관련 장애 치료 |
| CN121039163A (zh) | 2023-05-02 | 2025-11-28 | 瑞泽恩制药公司 | 抗人m-钙粘蛋白（cdh15）抗体、缀合物及其用于将遗传有效负载递送至肌肉细胞的用途 |
| IL325400A (en) | 2023-07-10 | 2026-02-01 | Regeneron Pharma | Anti-human CACNG1 antibody-drug conjugates and their uses |
| WO2025055311A1 (zh) * | 2023-09-15 | 2025-03-20 | 赛业（苏州）生物科技有限公司 | 用于制备抗体的基因修饰小鼠及其制备方法 |
| JP2026508379A (ja) * | 2023-09-15 | 2026-03-10 | 賽業（蘇州）生物科技有限公司 | 抗体を製造するための遺伝子改変マウスおよびその作製方法 |
| WO2025064738A1 (en) | 2023-09-22 | 2025-03-27 | Regeneron Pharmaceuticals, Inc. | Dntt 250-258 off-target peptides and uses thereof |
| WO2025064761A1 (en) | 2023-09-22 | 2025-03-27 | Regeneron Pharmaceuticals, Inc. | Kras10-18 g12d off-target peptides and uses thereof |
| CN118339300A (zh) * | 2024-01-02 | 2024-07-12 | 江苏集萃药康生物科技股份有限公司 | 产生人源化抗体的动物模型及其构建方法 |
| WO2026006724A1 (en) | 2024-06-28 | 2026-01-02 | Regeneron Pharmaceuticals, Inc. | Prame off-target peptides and uses thereof |
| WO2026006734A1 (en) | 2024-06-28 | 2026-01-02 | Regeneron Pharmaceuticals, Inc. | Off-target peptide-mhc complex conformation modeling systems and methods for antigen-recognition molecule development |
| WO2026030428A2 (en) | 2024-08-01 | 2026-02-05 | Regeneron Pharmaceuticals, Inc. | Prostate-specific antigen peptides and uses thereof |
| US20260123608A1 (en) | 2024-08-06 | 2026-05-07 | Regeneron Pharmaceuticals, Inc. | Non-human animals having modified immunoglobulin heavy chain constant region locus and uses thereof |
| WO2026096736A1 (en) | 2024-10-31 | 2026-05-07 | Regeneron Pharmaceuticals, Inc. | Rodents expressing humanized polymeric immunoglobulin receptor |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| WO1991000906A1 (en) | 1989-07-12 | 1991-01-24 | Genetics Institute, Inc. | Chimeric and transgenic animals capable of producing human antibodies |
| US6657103B1 (en) | 1990-01-12 | 2003-12-02 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US7041871B1 (en) | 1995-10-10 | 2006-05-09 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| CA2149025A1 (en) * | 1992-12-01 | 1994-06-09 | Man Sung Co | Humanized antibodies reactive with l-selectin |
| ATE549918T1 (de) | 1996-12-03 | 2012-04-15 | Amgen Fremont Inc | Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden |
| CN1203922A (zh) * | 1997-03-21 | 1999-01-06 | 三共株式会社 | 人源化抗人fas抗体 |
| US20020062010A1 (en) | 1997-05-02 | 2002-05-23 | Genentech, Inc. | Method for making multispecific antibodies having heteromultimeric and common components |
| RU10506U1 (ru) | 1999-04-08 | 1999-08-16 | Кривулин Виталий Николаевич | Ручной культиватор |
| JP2003501016A (ja) * | 1999-05-27 | 2003-01-14 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | Ａｄａｍのポリヌクレオチドおよびポリペプチド |
| GB0001448D0 (en) * | 2000-01-21 | 2000-03-08 | Novartis Ag | Organic compounds |
| US7105348B2 (en) | 2000-10-31 | 2006-09-12 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| TWI255272B (en) | 2000-12-06 | 2006-05-21 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
| US7034134B2 (en) | 2001-04-26 | 2006-04-25 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29 |
| EP1970448A1 (en) | 2001-05-11 | 2008-09-17 | Kirin Pharma Kabushiki Kaisha | Human artificial chromosome containting human antibody lambda light chain and non-human animal containting the human artificial chromosome capable of genetic transmission |
| US7473557B2 (en) | 2001-06-06 | 2009-01-06 | Regeneron Pharmaceuticals, Inc. | Method for targeting transcriptionally active loci |
| US20030108925A1 (en) | 2001-10-05 | 2003-06-12 | U.S. Epa | Genetic testing for male factor infertility |
| US20060199204A1 (en) | 2001-10-05 | 2006-09-07 | U.S. Epa | Genetic testing for male factor infertility |
| JP4099646B2 (ja) | 2002-06-04 | 2008-06-11 | 株式会社安川電機 | ボイスコイルモータ |
| EP2314629B2 (en) | 2002-07-18 | 2022-11-16 | Merus N.V. | Recombinant production of mixtures of antibodies |
| RU2251699C1 (ru) | 2003-09-25 | 2005-05-10 | Киселев Всеволод Иванович | Способ ранней и доклинической диагностики цервикального рака |
| WO2006044962A1 (en) | 2004-10-19 | 2006-04-27 | Regeneron Pharmaceuticals, Inc. | Method for generating an animal homozygous for a genetic modification |
| ATE416465T1 (de) | 2005-06-30 | 2008-12-15 | Borealis Tech Oy | Überzug-schicht für energie- oder kommunikationskabel |
| JP5514539B2 (ja) | 2006-03-31 | 2014-06-04 | メダレックス・リミテッド・ライアビリティ・カンパニー | ヒト抗体の調製に用いるためのキメラ抗体を発現するトランスジェニック動物 |
| NZ587107A (en) | 2006-06-02 | 2012-05-25 | Regeneron Pharma | High affinity antibodies to human il-6 receptor |
| WO2009097006A2 (en) | 2007-08-10 | 2009-08-06 | Medarex, Inc. | Hco32 and hco27 and related examples |
| US7659842B2 (en) | 2007-10-24 | 2010-02-09 | Infineon Technologies Ag | Quantization error reduction in PWM full-MASH converters |
| WO2010039900A2 (en) | 2008-09-30 | 2010-04-08 | Aliva Biopharmaceuticals, Inc. | Non-human mammals for the production of chimeric antibodies |
| CA2747534C (en) * | 2008-12-18 | 2020-08-18 | Erasmus University Medical Center Rotterdam | Non-human transgenic animals expressing humanised antibodies and use therof |
| GB0905023D0 (en) | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
| JP5399140B2 (ja) * | 2009-06-18 | 2014-01-29 | 株式会社タイトー | モールス信号通信システム |
| CN102638971B (zh) * | 2009-07-08 | 2015-10-07 | 科马布有限公司 | 动物模型及治疗分子 |
| DK2509409T3 (en) | 2009-12-10 | 2016-11-14 | Regeneron Pharma | MICE, WHICH PRODUCES HEAVY CHAIN ANTIBODIES |
| HRP20151188T4 (hr) | 2010-02-08 | 2021-10-01 | Regeneron Pharmaceuticals, Inc. | Miš sa zajedničkim lakim lancem |
| US20120021409A1 (en) | 2010-02-08 | 2012-01-26 | Regeneron Pharmaceuticals, Inc. | Common Light Chain Mouse |
| CN103228130B (zh) * | 2010-06-17 | 2016-03-16 | 科马布有限公司 | 动物模型及治疗分子 |
| LT2738259T (lt) | 2011-02-25 | 2020-03-10 | Regeneron Pharmaceuticals, Inc. | Adam6 pelės |
| PT3865581T (pt) | 2011-08-05 | 2024-10-04 | Regeneron Pharma | Murganhos da cadeia leve universal humanizada |
| KR20140082824A (ko) | 2011-10-17 | 2014-07-02 | 리제너론 파아마슈티컬스, 인크. | 제한된 면역글로불린 중쇄 마우스 |
| GB201118579D0 (en) | 2011-10-27 | 2011-12-07 | Micromass Ltd | Control of ion populations |
| US9253965B2 (en) * | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
| GB201122047D0 (en) * | 2011-12-21 | 2012-02-01 | Kymab Ltd | Transgenic animals |
| PT3527070T (pt) | 2011-12-20 | 2025-12-19 | Regeneron Pharma | Murganhos de cadeia leve humanizada |
| EP3912464A1 (en) | 2012-06-12 | 2021-11-24 | Regeneron Pharmaceuticals, Inc. | Humanized non-human animals with restricted immunoglobulin heavy chain loci |
-
2012
- 2012-02-24 LT LTEP14154967.5T patent/LT2738259T/lt unknown
- 2012-02-24 RS RS20150163A patent/RS53880B1/sr unknown
- 2012-02-24 DE DE14154967.5T patent/DE14154967T1/de active Pending
- 2012-02-24 PT PT141549675T patent/PT2738259T/pt unknown
- 2012-02-24 DK DK12716101.6T patent/DK2550363T3/en active
- 2012-02-24 EP EP14176593.3A patent/EP2813573B1/en active Active
- 2012-02-24 RU RU2016109443A patent/RU2722373C2/ru not_active Application Discontinuation
- 2012-02-24 SI SI201231675T patent/SI2578688T2/sl unknown
- 2012-02-24 ES ES12716101.6T patent/ES2532487T3/es active Active
- 2012-02-24 PL PL22156414.9T patent/PL4067496T3/pl unknown
- 2012-02-24 ES ES14176593T patent/ES2805364T3/es active Active
- 2012-02-24 PL PL12716101T patent/PL2550363T3/pl unknown
- 2012-02-24 DE DE14176593.3T patent/DE14176593T1/de active Pending
- 2012-02-24 CN CN201280010457.XA patent/CN103429746B/zh active Active
- 2012-02-24 LT LTEP14154918.8T patent/LT2738258T/lt unknown
- 2012-02-24 SG SG10201405135RA patent/SG10201405135RA/en unknown
- 2012-02-24 HU HUE22156414A patent/HUE062552T2/hu unknown
- 2012-02-24 PT PT12716101T patent/PT2550363E/pt unknown
- 2012-02-24 PT PT221564149T patent/PT4067496T/pt unknown
- 2012-02-24 PL PL14154967T patent/PL2738259T3/pl unknown
- 2012-02-24 SM SM20190581T patent/SMT201900581T1/it unknown
- 2012-02-24 SG SG10201913155QA patent/SG10201913155QA/en unknown
- 2012-02-24 DE DE14154918.8T patent/DE14154918T1/de active Pending
- 2012-02-24 HR HRP20230526TT patent/HRP20230526T1/hr unknown
- 2012-02-24 WO PCT/US2012/026416 patent/WO2012141798A1/en not_active Ceased
- 2012-02-24 EP EP14154918.8A patent/EP2738258B2/en active Active
- 2012-02-24 DK DK22156414.9T patent/DK4067496T5/da active
- 2012-02-24 CN CN201610204885.6A patent/CN105861548B/zh active Active
- 2012-02-24 NZ NZ813867A patent/NZ813867A/en unknown
- 2012-02-24 EP EP20170540.7A patent/EP3744850A1/en active Pending
- 2012-02-24 FI FIEP12192727.1T patent/FI2578688T4/fi active
- 2012-02-24 ES ES14154967T patent/ES2770424T3/es active Active
- 2012-02-24 HR HRP20192311TT patent/HRP20192311T4/hr unknown
- 2012-02-24 SM SM20200112T patent/SMT202000112T1/it unknown
- 2012-02-24 RS RS20200177A patent/RS59929B1/sr unknown
- 2012-02-24 EP EP22156414.9A patent/EP4067496B1/en active Active
- 2012-02-24 LT LTEP22156414.9T patent/LT4067496T/lt unknown
- 2012-02-24 MX MX2016013717A patent/MX375115B/es unknown
- 2012-02-24 MX MX2013009649A patent/MX343009B/es active IP Right Grant
- 2012-02-24 SI SI201231712T patent/SI2738258T2/sl unknown
- 2012-02-24 SI SI201232031T patent/SI4067496T1/sl unknown
- 2012-02-24 SG SG10201913160QA patent/SG10201913160QA/en unknown
- 2012-02-24 HU HUE12716101A patent/HUE024534T2/hu unknown
- 2012-02-24 ME MEP-2020-41A patent/ME03732B/me unknown
- 2012-02-24 EP EP12192727.1A patent/EP2578688B2/en active Active
- 2012-02-24 RS RS20230475A patent/RS64280B1/sr unknown
- 2012-02-24 BR BR112013021771-5A patent/BR112013021771B1/pt active IP Right Grant
- 2012-02-24 DE DE12192727T patent/DE12192727T1/de active Pending
- 2012-02-24 PL PL14154918.8T patent/PL2738258T5/pl unknown
- 2012-02-24 JP JP2013550677A patent/JP2014507137A/ja active Pending
- 2012-02-24 PT PT141549188T patent/PT2738258T/pt unknown
- 2012-02-24 HR HRP20150262AT patent/HRP20150262T1/hr unknown
- 2012-02-24 SG SG2013064159A patent/SG192933A1/en unknown
- 2012-02-24 ME MEP-2015-35A patent/ME02106B/me unknown
- 2012-02-24 PL PL12192727.1T patent/PL2578688T5/pl unknown
- 2012-02-24 CA CA2820824A patent/CA2820824A1/en not_active Withdrawn
- 2012-02-24 EP EP14154967.5A patent/EP2738259B1/en active Active
- 2012-02-24 AU AU2012243291A patent/AU2012243291B2/en active Active
- 2012-02-24 ME MEP2019272 patent/ME03537B/xx unknown
- 2012-02-24 NZ NZ731926A patent/NZ731926A/en unknown
- 2012-02-24 DE DE12716101T patent/DE12716101T1/de active Pending
- 2012-02-24 NZ NZ776770A patent/NZ776770A/en unknown
- 2012-02-24 ES ES22156414T patent/ES2946169T3/es active Active
- 2012-02-24 DK DK14176593.3T patent/DK2813573T1/da unknown
- 2012-02-24 ES ES14154918T patent/ES2758974T5/es active Active
- 2012-02-24 RS RS20191337A patent/RS59413B2/sr unknown
- 2012-02-24 SM SM20190744T patent/SMT201900744T1/it unknown
- 2012-02-24 HR HRP20191895TT patent/HRP20191895T4/hr unknown
- 2012-02-24 SI SI201230157T patent/SI2550363T1/sl unknown
- 2012-02-24 RS RS20191599A patent/RS59661B2/sr unknown
- 2012-02-24 HU HUE14154967A patent/HUE047687T2/hu unknown
- 2012-02-24 RU RU2013125717/10A patent/RU2582261C2/ru active
- 2012-02-24 ES ES12192727T patent/ES2748832T5/es active Active
- 2012-02-24 DK DK12192727.1T patent/DK2578688T4/da active
- 2012-02-24 HU HUE14154918A patent/HUE046746T2/hu unknown
- 2012-02-24 FI FIEP14154918.8T patent/FI2738258T4/fi active
- 2012-02-24 SM SM20230173T patent/SMT202300173T1/it unknown
- 2012-02-24 MY MYPI2013003123A patent/MY172713A/en unknown
- 2012-02-24 DK DK14154918.8T patent/DK2738258T4/da active
- 2012-02-24 LT LT12192727T patent/LT2578688T/lt unknown
- 2012-02-24 PT PT121927271T patent/PT2578688T/pt unknown
- 2012-02-24 HU HUE12192727A patent/HUE046081T2/hu unknown
- 2012-02-24 KR KR1020137025191A patent/KR101387377B1/ko active Active
- 2012-02-24 US US13/404,075 patent/US8642835B2/en active Active
- 2012-02-24 DK DK14154967.5T patent/DK2738259T3/da active
- 2012-02-24 IN IN7629CHN2013 patent/IN2013CN07629A/en unknown
- 2012-02-24 SI SI201231739T patent/SI2738259T1/sl unknown
- 2012-02-24 EP EP12716101.6A patent/EP2550363B1/en active Active
-
2013
- 2013-05-09 US US13/890,519 patent/US8697940B2/en active Active
- 2013-06-04 IL IL226727A patent/IL226727A/en active IP Right Grant
- 2013-08-08 ZA ZA2013/05998A patent/ZA201305998B/en unknown
- 2013-08-21 MX MX2020009714A patent/MX2020009714A/es unknown
-
2014
- 2014-02-27 US US14/192,051 patent/US9932408B2/en active Active
- 2014-03-20 JP JP2014057616A patent/JP5866127B2/ja active Active
-
2015
- 2015-01-20 US US14/600,829 patent/US10072095B2/en active Active
- 2015-02-26 JP JP2015036588A patent/JP2015107131A/ja not_active Withdrawn
- 2015-03-03 CY CY20151100221T patent/CY1116301T1/el unknown
- 2015-03-11 SM SM201500061T patent/SMT201500061B/xx unknown
- 2015-04-09 US US14/682,859 patent/US9944716B2/en active Active
- 2015-10-07 AU AU2015238806A patent/AU2015238806A1/en not_active Abandoned
-
2016
- 2016-04-27 JP JP2016088848A patent/JP2016135143A/ja not_active Withdrawn
-
2017
- 2017-10-26 AU AU2017251802A patent/AU2017251802A1/en not_active Abandoned
-
2018
- 2018-06-04 JP JP2018107070A patent/JP2018143250A/ja not_active Withdrawn
- 2018-08-09 US US16/059,821 patent/US10905108B2/en active Active
- 2018-08-09 US US16/059,871 patent/US10577430B2/en active Active
- 2018-08-09 US US16/059,884 patent/US10694725B2/en active Active
- 2018-08-09 US US16/059,922 patent/US10905109B2/en active Active
- 2018-08-20 IL IL261243A patent/IL261243B/en active IP Right Grant
-
2019
- 2019-07-09 JP JP2019127562A patent/JP2019187446A/ja not_active Withdrawn
- 2019-08-13 IL IL268671A patent/IL268671B/en active IP Right Grant
- 2019-09-19 CY CY20191100988T patent/CY1122205T1/el unknown
- 2019-10-23 CY CY20191101104T patent/CY1122459T1/el unknown
-
2020
- 2020-01-22 CY CY20201100054T patent/CY1122820T1/el unknown
- 2020-02-21 AU AU2020201279A patent/AU2020201279A1/en not_active Abandoned
- 2020-02-21 HR HRP20200294TT patent/HRP20200294T1/hr unknown
- 2020-04-16 IL IL273986A patent/IL273986B/en active IP Right Grant
- 2020-12-21 US US17/129,708 patent/US11950578B2/en active Active
- 2020-12-21 US US17/129,706 patent/US12207628B2/en active Active
-
2022
- 2022-02-11 FI FIEP22156414.9T patent/FI4067496T3/fi active
- 2022-02-28 JP JP2022029501A patent/JP2022071051A/ja active Pending
- 2022-07-22 AU AU2022206806A patent/AU2022206806B2/en active Active
-
2023
- 2023-05-31 CY CY20231100256T patent/CY1126091T1/el unknown
-
2024
- 2024-03-06 US US18/597,797 patent/US20240306617A1/en active Pending
- 2024-12-05 JP JP2024212173A patent/JP2025032218A/ja active Pending
-
2025
- 2025-12-17 AU AU2025283466A patent/AU2025283466A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014127339A (ru) | Мыши с гуманизированной легкой цепью | |
| JP2015505477A5 (enExample) | ||
| RU2014153673A (ru) | Гуманизированные не относящиеся к человеку животные с ограниченными локусами тяжелой цепи иммуноглобулина | |
| RU2014133653A (ru) | Гуманизированные грызуны, которые экспрессируют тяжелые цепи, содержащие домены vl | |
| JP2021137030A5 (enExample) | ||
| JP2015525071A5 (enExample) | ||
| JP2015519076A5 (enExample) | ||
| JP2015502177A5 (enExample) | ||
| RU2016109443A (ru) | Мыши adam6 | |
| JP2018138047A5 (enExample) | ||
| JP2016512034A5 (enExample) | ||
| JP2019083823A5 (enExample) | ||
| JP2012532598A5 (enExample) | ||
| RU2019112589A (ru) | Отличные от человека животные со сконструированным локусом легкой лямбда-цепи иммуноглобулина | |
| JP2020530760A5 (enExample) | ||
| JP2015519055A5 (enExample) | ||
| WO2014160202A4 (en) | Mice expressing a limited immunoglobulin light chain repertoire | |
| RU2016141307A (ru) | Отличные от человека животные, которые вырабатывают однодоменные связывающие белки | |
| JP2014524243A5 (enExample) | ||
| HUE029785T2 (en) | Common light chain mouse | |
| JP2015509380A5 (enExample) | ||
| JP2015534819A5 (enExample) | ||
| JP2013535213A5 (enExample) | ||
| JP2013198489A5 (enExample) | ||
| HUE034386T2 (en) | Production of binding molecules |